System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Letter Epublish

PubMed: 42491622 DOI: 10.1016/j.isci.2025.114513

Randomized clinical trials of COVID-19 vaccines are not designed to study non-specific effects on rare mortality.

iScience 29(7):114513

Authors: Lonni Besançon, Steve Claude, Nicolas Dauby, Thomas Kesteman, Gideon Meyerowitz-Katz, Clémence Leyrat

Affiliations

  • Media and Information Technology, Linköping University, Linköping, Sweden.
  • Pharmacist, Delémont, Switzerland.
  • Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • U-CRI, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Oxford University Clinical Research Unit, Hanoi, Vietnam.
  • School of Health and Society, University of Wollongong, Wollongong, NSW, Australia.
  • Department of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

MeSH

Mortality, Vaccines, Covid-19 Vaccines, Covid-19